Skip to content

Clinical trials

Terminated Macular Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Status: Terminated Clear all

107 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20044
20053
20067
200712
20086
20094
20106
20112
20127
20135
201410
20159
20162
20175
20183
20196
20203
20215
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated107

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alcon Research5
Ophthotech Corporation5
Pfizer5
Genaera Corporation4
National Eye Institute (NEI)4
Novartis Pharmaceuticals4
Allergan3
Asociación para Evitar la Ceguera en México3
Bayer2
Boehringer Ingelheim2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration107
Choroidal Neovascularization18
Geographic Atrophy14
Retinal Diseases10
Diabetic Retinopathy8
Retinal Degeneration8
Eye Diseases7
Alzheimer Disease3
Macular Edema3
Parkinson Disease3

Trials

Showing 76 to 100 of 107. Each trial links to its page on Pharma Observatory.

7 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.